SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002098
Filing Date
2018-08-01
Accepted
2018-08-01 15:03:46
Documents
41
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-063018.htm 10-Q 185298
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER proteo_10q-ex3101.htm EX-31.1 8977
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER proteo_10q-ex3102.htm EX-31.2 8978
4 CERTIFICATION proteo_10q-ex3200.htm EX-32 5152
  Complete submission text file 0001683168-18-002098.txt   1117847

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20180630.xml EX-101.INS 117640
6 XBRL SCHEMA FILE pteo-20180630.xsd EX-101.SCH 15478
7 XBRL CALCULATION FILE pteo-20180630_cal.xml EX-101.CAL 30523
8 XBRL DEFINITION FILE pteo-20180630_def.xml EX-101.DEF 35841
9 XBRL LABEL FILE pteo-20180630_lab.xml EX-101.LAB 102960
10 XBRL PRESENTATION FILE pteo-20180630_pre.xml EX-101.PRE 87204
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 18984414
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1